The systemic sensitization with DNP-As produced allergy-induced experimental endolymphatic hydrops with type 1 hypersensitivity allergic reaction, and the development of these endolymphatic hydrops was prevented by H1R antagonists. The gene discussed is HRH1; the disease is endolymphatic hydrops.